.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Merck
Harvard Business School
Julphar
Accenture
Chubb
Deloitte
Citi
Novartis

Generated: June 24, 2017

DrugPatentWatch Database Preview

PHOTOFRIN Drug Profile

« Back to Dashboard

Which patents cover Photofrin, and what generic Photofrin alternatives are available?

Photofrin is a drug marketed by Concordia Labs Inc and is included in one NDA.

The generic ingredient in PHOTOFRIN is porfimer sodium. One supplier is listed for this compound. Additional details are available on the porfimer sodium profile page.

Summary for Tradename: PHOTOFRIN

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list20
Drug Prices:see details
DailyMed Link:PHOTOFRIN at DailyMed

Pharmacology for Tradename: PHOTOFRIN

Drug ClassPhotoactivated Radical Generator
Mechanism of ActionPhotoabsorption
Physiological EffectPhotosensitizing Activity
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Concordia Labs Inc
PHOTOFRIN
porfimer sodium
INJECTABLE;INJECTION020451-001Dec 27, 1995RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PHOTOFRIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Concordia Labs Inc
PHOTOFRIN
porfimer sodium
INJECTABLE;INJECTION020451-001Dec 27, 19955,028,621► Subscribe
Concordia Labs Inc
PHOTOFRIN
porfimer sodium
INJECTABLE;INJECTION020451-001Dec 27, 19955,438,071► Subscribe
Concordia Labs Inc
PHOTOFRIN
porfimer sodium
INJECTABLE;INJECTION020451-001Dec 27, 19954,649,151► Subscribe
Concordia Labs Inc
PHOTOFRIN
porfimer sodium
INJECTABLE;INJECTION020451-001Dec 27, 19955,145,863► Subscribe
Concordia Labs Inc
PHOTOFRIN
porfimer sodium
INJECTABLE;INJECTION020451-001Dec 27, 19954,932,934► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Mallinckrodt
Merck
Moodys
Chubb
Chinese Patent Office
Johnson and Johnson
Julphar
UBS
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot